Peter Lukacs
Overview
Explore the profile of Peter Lukacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lukacs P, Stratoudaki T, Davis G, Gachagan A
Sci Rep
. 2024 Apr;
14(1):8541.
PMID: 38609508
Ultrasonic imaging, using ultrasonic phased arrays, has an enormous impact in science, medicine and society and is a widely used modality in many application fields. The maximum amount of information...
2.
Zboray K, Toth A, Miskolczi T, Pesti K, Casanova E, Kreidl E, et al.
Sci Rep
. 2023 Dec;
13(1):21757.
PMID: 38066004
Agriculturally important crop plants emit a multitude of volatile organic compounds (VOCs), which are excellent indicators of their health status and their interactions with pathogens and pests. In this study,...
3.
Hackl B, Lukacs P, Ebner J, Pesti K, Haechl N, Foldi M, et al.
Front Pharmacol
. 2022 May;
13:809802.
PMID: 35586063
Ivabradine is clinically administered to lower the heart rate, proposedly by inhibiting hyperpolarization-activated cyclic nucleotide-gated cation channels in the sinoatrial node. Recent evidence suggests that voltage-gated sodium channels (VGSC) are...
4.
Lukacs P, Pietrikova A, Vehec I, Provazek P
Polymers (Basel)
. 2022 Feb;
14(3).
PMID: 35160496
The design, simulation, realization, and measurement of an ultra-wideband (UWB) antenna on a polymeric substrate have been realized. The UWB antenna was prepared using conventional technology, such as copper etching;...
5.
Lukacs P, Pesti K, Foldi M, Zboray K, Toth A, Papp G, et al.
Front Pharmacol
. 2021 Oct;
12:738260.
PMID: 34658875
Standard high throughput screening projects using automated patch-clamp instruments often fail to grasp essential details of the mechanism of action, such as binding/unbinding dynamics and modulation of gating. In this...
6.
Pesti K, Foldi M, Zboray K, Toth A, Lukacs P, Mike A
Front Pharmacol
. 2021 Sep;
12:738460.
PMID: 34497526
We have developed an automated patch-clamp protocol that allows high information content screening of sodium channel inhibitor compounds. We have observed that individual compounds had their specific signature patterns of...
7.
Foldi M, Pesti K, Zboray K, Toth A, Hegedus T, Malnasi-Csizmadia A, et al.
Br J Pharmacol
. 2021 Jan;
178(5):1200-1217.
PMID: 33450052
Background And Purpose: Sodium channel inhibitors can be used to treat hyperexcitability-related diseases, including epilepsies, pain syndromes, neuromuscular disorders and cardiac arrhythmias. The applicability of these drugs is limited by...
8.
Pesti K, Lukacs P, Mike A
PeerJ
. 2019 Sep;
7:e7542.
PMID: 31534841
Cognitive impairment often involves the decreased expression or hypofunction of alpha 7-type nicotinic acetylcholine receptors (α7 nAChRs). Agonists or positive allosteric modulators (PAMs) of α7 nAChRs are known to be...
9.
Lukacs P, Foldi M, Valanszki L, Casanova E, Biri-Kovacs B, Nyitray L, et al.
Sci Rep
. 2018 May;
8(1):8110.
PMID: 29802266
Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge...
10.
Cervenka R, Lukacs P, Gawali V, Ke S, Koenig X, Rubi L, et al.
Sci Rep
. 2018 Jan;
8(1):631.
PMID: 29330525
Inactivation of voltage-gated Na channels (VGSC) is essential for the regulation of cellular excitability. The molecular rearrangement underlying inactivation is thought to involve the intracellular linker between domains III and...